On Thursday, Stifel Nicolaus raised its price target on Ichor from $21.00 to $25.00 and maintained a hold rating, prompting a notable pre‐market gap higher. Over the past two months, Oppenheimer upgraded the stock from market perform to outperform and also boosted its target to $25.00, while DA Davidson trimmed its forecast from $35.00 to $30.00 but retained a buy rating. Conversely, Wall Street Zen cut its assessment to strong sell and Weiss Ratings stuck with a sell (D-) grade. In total, four analysts rate Ichor a buy, four rate it a hold and one recommends sell, yielding a consensus price target of $26.00, per MarketBeat data.

Director Iain Mackenzie acquired 10,000 shares on November 17 at an average cost of $14.53 per share, investing $145,300 and increasing his stake by 8.33% to 130,011 shares valued at $1.89 million. This purchase raised insider ownership to 1.90% of the company’s outstanding stock, signaling confidence at the board level in Ichor’s growth prospects within its semiconductor subsystem niche.

Institutional investors control 94.81% of Ichor’s float. In Q1, Royal Bank of Canada lifted its holding by 27.7% to 9,891 shares, MIRAE ASSET GLOBAL ETFS added 4.6% to reach 19,645 shares, and Jane Street Group boosted its position 286% to 53,277 shares. Rhumbline Advisers and Farther Finance Advisors also increased stakes, reflecting broad institutional conviction despite mixed analyst sentiment.

For the fiscal Q3 ended November 3, Ichor generated revenue of $239.3 million, up 13.4% year-over-year, yet missed consensus EPS estimates by $0.05, posting $0.07 per share and yielding a negative net margin of 4.26% and return on equity of –0.96%. The balance sheet remains healthy with a quick ratio of 1.33, current ratio of 3.08 and debt-to-equity of 0.17. Management’s Q4 guidance targets EPS between –0.14 and –0.02, while analysts forecast full-year EPS of 1.01. The company trades with a market capitalization just under $1 billion and a beta of 1.83.